Article, Drug Development and Fragment Screening

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Article

Drug Development

Fragment Screening

Advancements in hit identification for membrane protein drug discovery

Drug Target Review

APRIL 7, 2025

GPCRs are critical targets for drug development due to their involvement in numerous disease pathologies, with many medications working by either activating or inhibiting these receptors. 2022) Why 90% of clinical drug development fails and how to improve it?, References Sun D, et al. doi:10.1016/j.apsb.2022.02.002.

Fragment Screening

Fragment Screening Drugs Small Molecule Biophysical Assays

SARS-CoV-2 Protease Inhibitors: An Attractive Approach for Treating COVID-19

PerkinElmer

JUNE 3, 2022

The second virtual screen focused on optimization of a hit from a previous crystallographic fragment screen. Fragment-to-lead optimization was guided by searches in a library of millions of compounds combined with docking screens to select the best candidate.

Fragment Screening

Fragment Screening Clinical Trials Vaccine Pharmacokinetics

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Drug Discovery Digest

Advancements in hit identification for membrane protein drug discovery

SARS-CoV-2 Protease Inhibitors: An Attractive Approach for Treating COVID-19

Webinars

Stay Connected